Implantable cardiac monitoring versus conventional monitoring following cryptogenic stroke

Takeaway

  • Implantable cardiac monitoring (ICM) was independently associated with increased likelihood of paroxysmal atrial fibrillation (PAF) detection and anticoagulation initiation following a cryptogenic ischemic stroke (CIS) or transient ischemic attack (TIA), and was associated with lower risk of stroke recurrence.

Why this matters

    There are little available data on optimal screening or utility of ICM for detection of PAF following CIS or TIA. Understanding the effectiveness of ICM may help improve patient outcomes.